Table 1 of
Sharma, Mol Vis 2025; 31:276-280. Table 1 of
Sharma, Mol Vis 2025; 31:276-280.
Table 1. The demographic data, biochemical and clinical indicators of cases (n=66) and controls (n=22).
| Variables | Control | NoDR | NPDR | PDR | F/χ2 value | p-value |
|---|---|---|---|---|---|---|
| Age (years) | 55.18±5.18 | 54.82±5.47 | 54.23±6.78 | 54.77±6.11 | 0.097 | 0.961 |
| Male | 12 (54.5%) | 11 (50.0%) | 15 (68.2%) | 18 (81.8%) | 6.93 | 0.117 |
| Female | 10 (45.5%) | 11 (50.0%) | 7 (31.8%) | 4 (18.2%) | ||
| Hemoglobin (gm%) | 12.68±0.71 | 12.31±1.00 | 11.04±0.61 | 11.43±0.57 | 22.590 | <0.001 |
| Fasting plasma glucose (mg/dl) | 88.41±20.40 | 112.77±14.98 | 125.76±36.08 | 150.32±46.04 | 14.445 | <0.001 |
| 2-h plasma glucose (mg/dl) | 121.95±17.99 | 166.91±19.84 | 201.37±51.09 | 211.59±66.80 | 18.496 | <0.001 |
| HbA1c (%) | 4.76±0.49 | 7.72±0.44 | 8.48±1.50 | 9.09±1.13 | 80.925 | <0.001 |
| Serum urea (mg/dl) | 19.06±31.97 | 18.41±4.33 | 29.41±4.29 | 36.56±12.87 | 46.640 | 0.002 |
| Serum creatinine(mg/dl) | 0.83±0.17 | 0.94±0.22 | 1.13±0.22 | 1.66±0.39 | 27.422 | <0.001 |
| Serum Pro BNP (pg/ml) | 14.90±12.04 | 27.76±12.19 | 278.40±105.39 | 118.53±44.62 | 96.897 | <0.001 |
| BCVA (logMAR; RE) | 0.30±0.18 | 0.38±0.13 | 0.66±0.49 | 1.15±0.44 | 26.834 | <0.001 |
| BCVA (logMAR; LE) | 0.25±0.15 | 0.43±0.14 | 0.57±0.39 | 1.18±0.54 | 28.717 | <0.001 |